1-3 of 3
Francesca Antoniazzi, MD
Close
Sort by
Journal Articles

WT1 Monitoring of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia

Michele Malagola, Crisitina Skert, Enrico Morello, MD, Francesca Antoniazzi, MD, Erika Borlenghi, MD, Alessandro Turra, Chiara Pagani, MD, Rossella Ribolla, Valeria Cancelli, Federica Cattina, MD PhD, Elisa Alghisi, Simona Bernardi, Simone Perucca, Andrea Di Palma, Giuseppina Ruggeri, Giuseppe Rossi, Luigi Caimi, Domenico Russo, MD
Journal: Blood
Blood (2014) 124 (21): 3695.
https://doi.org/10.1182/blood.V124.21.3695.3695
Published: 2014
Journal Articles

Impact Of Posaconazole Prophylaxis On Invasive Fungal Infection During Acute Myeloid Leukemia Induction Therapy: Correlation With Posaconazole Serum Levels

Chiara Cattaneo, MD, Erika Borlenghi, MD, Annafranca Panzali, Francesca Antoniazzi, MD, Marta Petullà, Francesca Schieppati, MD, Elisa Cerqui, MD, Chiara Pagani, MD, Alessandro Re, MD, Giuseppe Rossi
Journal: Blood
Blood (2013) 122 (21): 3484.
https://doi.org/10.1182/blood.V122.21.3484.3484
Published: 2013
Journal Articles

Plasmablastic Lymphoma Among HIV-Positive Patients: A Curable Entity? Results of a Single Centre's Experience

Chiara Cattaneo, MD, Alessandro Re, MD, Annalisa Peli, MD, Salvatore Casari, MD, Stefano Fogazzi, MD, Francesca Antoniazzi, MD, Chiara Pagani, MD, Francesca Schieppati, MD, Alfredo Scalzini, MD, Francesco Castelli, MD, Giuseppe Rossi
Journal: Blood
Blood (2012) 120 (21): 3640.
https://doi.org/10.1182/blood.V120.21.3640.3640
Published: 2012